These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 19361352)

  • 1. Osteopontin: a multifunctional protein at the crossroads of inflammation, atherosclerosis, and vascular calcification.
    Cho HJ; Cho HJ; Kim HS
    Curr Atheroscler Rep; 2009 May; 11(3):206-13. PubMed ID: 19361352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteopontin: a multifunctional molecule regulating chronic inflammation and vascular disease.
    Scatena M; Liaw L; Giachelli CM
    Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2302-9. PubMed ID: 17717292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteopontin in Vascular Disease.
    Lok ZSY; Lyle AN
    Arterioscler Thromb Vasc Biol; 2019 Apr; 39(4):613-622. PubMed ID: 30727754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteopontin - a multi-modal marker and mediator in atherosclerotic vascular disease.
    Wolak T
    Atherosclerosis; 2014 Oct; 236(2):327-37. PubMed ID: 25128758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular calcification and aortic fibrosis: a bifunctional role for osteopontin in diabetic arteriosclerosis.
    Shao JS; Sierra OL; Cohen R; Mecham RP; Kovacs A; Wang J; Distelhorst K; Behrmann A; Halstead LR; Towler DA
    Arterioscler Thromb Vasc Biol; 2011 Aug; 31(8):1821-33. PubMed ID: 21597007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Osteopontin in Atherosclerosis and Its Clinical Manifestations (Atherosclerotic Cardiovascular Diseases)-A Narrative Review.
    Kadoglou NPE; Khattab E; Velidakis N; Gkougkoudi E
    Biomedicines; 2023 Nov; 11(12):. PubMed ID: 38137398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular determinants of vascular calcification: a bench to bedside view.
    Dellegrottaglie S; Sanz J; Rajagopalan S
    Curr Mol Med; 2006 Aug; 6(5):515-24. PubMed ID: 16918372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of osteopontin messenger RNA by macrophages in atherosclerotic plaques. A possible association with calcification.
    Hirota S; Imakita M; Kohri K; Ito A; Morii E; Adachi S; Kim HM; Kitamura Y; Yutani C; Nomura S
    Am J Pathol; 1993 Oct; 143(4):1003-8. PubMed ID: 8213995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-terminal rather than full-length osteopontin or its C-terminal fragment is associated with carotid-plaque inflammation in hypertensive patients.
    Wolak T; Sion-Vardi N; Novack V; Greenberg G; Szendro G; Tarnovscki T; Nov O; Shelef I; Paran E; Rudich A
    Am J Hypertens; 2013 Mar; 26(3):326-33. PubMed ID: 23382482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteopontin/SPP1: a potential mediator between immune cells and vascular calcification.
    Zhao Y; Huang Z; Gao L; Ma H; Chang R
    Front Immunol; 2024; 15():1395596. PubMed ID: 38919629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inactivation of the osteopontin gene enhances vascular calcification of matrix Gla protein-deficient mice: evidence for osteopontin as an inducible inhibitor of vascular calcification in vivo.
    Speer MY; McKee MD; Guldberg RE; Liaw L; Yang HY; Tung E; Karsenty G; Giachelli CM
    J Exp Med; 2002 Oct; 196(8):1047-55. PubMed ID: 12391016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The multiple functions and mechanisms of osteopontin.
    Icer MA; Gezmen-Karadag M
    Clin Biochem; 2018 Sep; 59():17-24. PubMed ID: 30003880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteopontin: A Promising Therapeutic Target in Cardiac Fibrosis.
    Abdelaziz Mohamed I; Gadeau AP; Hasan A; Abdulrahman N; Mraiche F
    Cells; 2019 Dec; 8(12):. PubMed ID: 31816901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptide-based vaccination against OPN integrin binding sites does not improve cardio-metabolic disease in mice.
    Grün NG; Strohmeier K; Moreno-Viedma V; Le Bras M; Landlinger C; Zeyda K; Wanko B; Leitner L; Staffler G; Zeyda M; Stulnig TM
    Immunol Lett; 2016 Nov; 179():85-94. PubMed ID: 27639826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular calcification is not related to serum fetuin-A and osteopontin levels in hemodialysis patients.
    Ulutas O; Taskapan MC; Dogan A; Baysal T; Taskapan H
    Int Urol Nephrol; 2018 Jan; 50(1):137-142. PubMed ID: 29134617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteopontin deficiency dampens the pro-atherogenic effect of uraemia.
    Pedersen TX; Madsen M; Junker N; Christoffersen C; Vikeså J; Bro S; Hultgårdh-Nilsson A; Nielsen LB
    Cardiovasc Res; 2013 Jun; 98(3):352-9. PubMed ID: 23455547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteopontin regulates macrophage activation and osteoclast formation in hypertensive patients with vascular calcification.
    Ge Q; Ruan CC; Ma Y; Tang XF; Wu QH; Wang JG; Zhu DL; Gao PJ
    Sci Rep; 2017 Jan; 7():40253. PubMed ID: 28091516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of osteopontin as a core protein in craniopharyngioma calcification formation.
    Qi S; Huang G; Pan J; Li J; Zhang X; Fang L; Liu B; Meng W; Zhang Y; Liu X
    J Neurooncol; 2010 May; 98(1):21-30. PubMed ID: 19902145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble osteopontin and vascular calcification in hemodialysis patients.
    Nitta K; Ishizuka T; Horita S; Hayashi T; Ajiro A; Uchida K; Honda K; Oba T; Kawashima A; Yumura W; Kabaya T; Akiba T; Nihei H
    Nephron; 2001 Dec; 89(4):455-8. PubMed ID: 11721165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteopontin upregulation in atherogenesis is associated with cellular oxidative stress triggered by the activation of scavenger receptors.
    Jiménez-Corona AE; Damián-Zamacona S; Pérez-Torres A; Moreno A; Mas-Oliva J
    Arch Med Res; 2012 Feb; 43(2):102-11. PubMed ID: 22410136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.